Pasireotide diaspartate

Description: Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. Target: Others. Smiles: N[C@@H](CC(O)=O)C(O)=O.N[C@@H](CC(O)=O)C(O)=O.[H][C@@]12C[C@H](CN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(OCc3ccccc3)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c3ccccc13)NC(=O)[C@H](NC2=O)c1ccccc1)OC(=O)NCCN. References: Silverstein JM. Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly. Pituitary. 2016 Oct,19(5):536-43. doi: 10.1007/s11102-016-0734-1. Review. PubMed PMID: 27405306.